| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 81, 4264-4267, Copyright © 1996 by Endocrine Society
ARTICLES |
L Yu, M Rewers, R Gianani, E Kawasaki, Y Zhang, C Verge, P Chase, G Klingensmith, H Erlich, J Norris and GS Eisenbarth
Barbara Davis Center for Childhood Diabetes, University of Colorado, Denver 80262, USA.
The goal of this study was to address whether antiislet autoantibodies appear sequentially or simultaneously before the onset of type I diabetes. We analyzed sequential serum samples from 155 siblings and offspring (aged < 7 yr) of patients with type I diabetes from the Denver Diabetes Autoimmunity Study in the Young study and from a separate group of first degree relatives (aged 2-40 yr) for autoantibodies reacting with three defined autoantigens: glutamic acid decarboxylase (GAD65), insulin, and ICA512/IA-2. The youngest age at which 1 of the 3 autoantibodies appeared was 1.1 yr, and the oldest was 60.9 yr. Of the total 26 autoantibody conversion events observed, in only 3 instances did more than 1 autoantibody appear simultaneously. Among individuals (n = 12) with sequential conversion to expression of multiple autoantibodies, anti-GAD65 autoantibodies or antiinsulin autoantibodies appeared first (4 expressed antiinsulin autoantibodies first, and 8 anti-GAD65 autoantibodies first). We conclude that antiislet autoantibodies usually appear sequentially and not simultaneously. This corroborates early suggestions that humoral autoimmunity to islets develops chronically in a process usually measured in months to years. As expression of multiple autoantibodies is associated with a high risk of progression to diabetes, and sequential appearance of autoantibodies can occur late in life, long term follow-up is necessary to fully delineate the relationship of diabetes risk to autoantibody expression.
This article has been cited by other articles:
![]() |
T. Orban, J. M. Sosenko, D. Cuthbertson, J. P. Krischer, J. S. Skyler, R. Jackson, L. Yu, J. P. Palmer, D. Schatz, G. Eisenbarth, et al. Pancreatic Islet Autoantibodies as Predictors of Type 1 Diabetes in the Diabetes Prevention Trial-Type 1 Diabetes Care, December 1, 2009; 32(12): 2269 - 2274. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Herold, B. Brooks-Worrell, J. Palmer, H. M. Dosch, M. Peakman, P. Gottlieb, H. Reijonen, S. Arif, L. M. Spain, C. Thompson, et al. Validity and Reproducibility of Measurement of Islet Autoreactivity by T-Cell Assays in Subjects With Early Type 1 Diabetes Diabetes, November 1, 2009; 58(11): 2588 - 2595. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Steck, W. Zhang, T. L. Bugawan, K. J. Barriga, A. Blair, H. A. Erlich, G. S. Eisenbarth, J. M. Norris, and M. J. Rewers Do Non-HLA Genes Influence Development of Persistent Islet Autoimmunity and Type 1 Diabetes in Children With High-Risk HLA-DR,DQ Genotypes? Diabetes, April 1, 2009; 58(4): 1028 - 1033. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yu, A. K. Steck, S. Babu, L. Yu, D. Miao, K. McFann, J. Hutton, G. S. Eisenbarth, and G. Klingensmith Single Nucleotide Transcription Factor 7-Like 2 (TCF7L2) Gene Polymorphisms in Antiislet Autoantibody-Negative Patients at Onset of Diabetes J. Clin. Endocrinol. Metab., February 1, 2009; 94(2): 504 - 510. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Akirav, J. A. Kushner, and K. C. Herold {beta}-Cell Mass and Type 1 Diabetes: Going, Going, Gone? Diabetes, November 1, 2008; 57(11): 2883 - 2888. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Lamb, X. Yin, K. Barriga, M. R. Hoffman, A. E. Baron, G. S. Eisenbarth, M. Rewers, and J. M. Norris Dietary Glycemic Index, Development of Islet Autoimmunity, and Subsequent Progression to Type 1 Diabetes in Young Children J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3936 - 3942. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tsui, V. Naik, N. Hoa, C. J. Hwang, N. F. Afifiyan, A. Sinha Hikim, A. G. Gianoukakis, R. S. Douglas, and T. J. Smith Evidence for an Association between Thyroid-Stimulating Hormone and Insulin-Like Growth Factor 1 Receptors: A Tale of Two Antigens Implicated in Graves' Disease J. Immunol., September 15, 2008; 181(6): 4397 - 4405. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Makinen, T. Harkonen, J. Ilonen, M. Knip, and the Finnish Pediatric Diabetes Register Characterization of the humoral immune response to islet antigen 2 in children with newly diagnosed type 1 diabetes. Eur. J. Endocrinol., July 1, 2008; 159(1): 19 - 26. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Norris, X. Yin, M. M. Lamb, K. Barriga, J. Seifert, M. Hoffman, H. D. Orton, A. E. Baron, M. Clare-Salzler, H. P. Chase, et al. Omega-3 Polyunsaturated Fatty Acid Intake and Islet Autoimmunity in Children at Increased Risk for Type 1 Diabetes JAMA, September 26, 2007; 298(12): 1420 - 1428. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, D. Miao, S. Babu, J. Yu, J. Barker, G. Klingensmith, M. Rewers, G. S. Eisenbarth, and L. Yu Prevalence of Autoantibody-Negative Diabetes Is Not Rare at All Ages and Increases with Older Age and Obesity J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 88 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Seyfert-Margolis, T. D. Gisler, A. L. Asare, R. S. Wang, H. M. Dosch, B. Brooks-Worrell, G. S. Eisenbarth, J. P. Palmer, C. J. Greenbaum, S. E. Gitelman, et al. Analysis of T-Cell Assays to Measure Autoimmune Responses in Subjects With Type 1 Diabetes: Results of a Blinded Controlled Study Diabetes, September 1, 2006; 55(9): 2588 - 2594. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Redondo, S. Babu, A. Zeidler, T. Orban, L. Yu, C. Greenbaum, J. P. Palmer, D. Cuthbertson, G. S. Eisenbarth, J. P. Krischer, et al. Specific Human Leukocyte Antigen DQ Influence on Expression of Antiislet Autoantibodies and Progression to Type 1 Diabetes J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1705 - 1713. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Barker Type 1 Diabetes-Associated Autoimmunity: Natural History, Genetic Associations, and Screening J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1210 - 1217. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Sherry, E. B. Tsai, and K. C. Herold Natural History of {beta}-Cell Function in Type 1 Diabetes Diabetes, December 1, 2005; 54(suppl_2): S32 - S39. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Steck, T. L. Bugawan, A. M. Valdes, L. M. Emery, A. Blair, J. M. Norris, M. J. Redondo, S. R. Babu, H. A. Erlich, G. S. Eisenbarth, et al. Association of Non-HLA Genes With Type 1 Diabetes Autoimmunity Diabetes, August 1, 2005; 54(8): 2482 - 2486. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Steck, K. J. Barriga, L. M. Emery, R. V. Fiallo-Scharer, P. A. Gottlieb, and M. J. Rewers Secondary Attack Rate of Type 1 Diabetes in Colorado Families Diabetes Care, February 1, 2005; 28(2): 296 - 300. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. B. Murinson, M. Butler, K. Marfurt, S. Gleason, P. De Camilli, and M. Solimena Markedly elevated GAD antibodies in SPS: Effects of age and illness duration Neurology, December 14, 2004; 63(11): 2146 - 2148. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Devendra, B. Franke, T. S. Galloway, S. J. Horton, M. Knip, and T. J. Wilkin Distinct Idiotypes of Insulin Autoantibody in Autoimmune Polyendocrine Syndrome Type 2 and Childhood Onset Type 1 Diabetes J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 5266 - 5270. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P. Chase, S. Cooper, I. Osberg, L. C. Stene, K. Barriga, J. Norris, G. S. Eisenbarth, and M. Rewers Elevated C-Reactive Protein Levels in the Development of Type 1 Diabetes Diabetes, October 1, 2004; 53(10): 2569 - 2573. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Krischer, D. D. Cuthbertson, and C. Greenbaum Male Sex Increases the Risk of Autoimmunity but not Type 1 Diabetes Diabetes Care, August 1, 2004; 27(8): 1985 - 1990. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Stene, K. Barriga, J. M. Norris, M. Hoffman, H. A. Erlich, G. S. Eisenbarth, R. S. McDuffie Jr., and M. Rewers Perinatal Factors and Development of Islet Autoimmunity in Early Childhood: The Diabetes Autoimmunity Study in the Young Am. J. Epidemiol., July 1, 2004; 160(1): 3 - 10. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Barker, S. H. Goehrig, K. Barriga, M. Hoffman, R. Slover, G. S. Eisenbarth, J. M. Norris, G. J. Klingensmith, and M. Rewers Clinical Characteristics of Children Diagnosed With Type 1 Diabetes Through Intensive Screening and Follow-Up Diabetes Care, June 1, 2004; 27(6): 1399 - 1404. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Siebold, B. E. Hansen, J. R. Wyer, K. Harlos, R. E. Esnouf, A. Svejgaard, J. I. Bell, J. L. Strominger, E. Y. Jones, and L. Fugger Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy PNAS, February 17, 2004; 101(7): 1999 - 2004. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Stanley, J. M. Norris, K. Barriga, M. Hoffman, L. Yu, D. Miao, H. A. Erlich, G. S. Eisenbarth, and M. Rewers Is Presence of Islet Autoantibodies at Birth Associated With Development of Persistent Islet Autoimmunity?: The Diabetes Autoimmunity Study in the Young (DAISY) Diabetes Care, February 1, 2004; 27(2): 497 - 502. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Fronczak, A. E. Baron, H. P. Chase, C. Ross, H. L. Brady, M. Hoffman, G. S. Eisenbarth, M. Rewers, and J. M. Norris In Utero Dietary Exposures and Risk of Islet Autoimmunity in Children Diabetes Care, December 1, 2003; 26(12): 3237 - 3242. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Stene, K. Barriga, J. M. Norris, M. Hoffman, G. Klingensmith, H. A. Erlich, G. S. Eisenbarth, and M. Rewers Symptoms of Common Maternal Infections in Pregnancy and Risk of Islet Autoimmunity in Early Childhood Diabetes Care, November 1, 2003; 26(11): 3136 - 3141. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Norris, K. Barriga, G. Klingensmith, M. Hoffman, G. S. Eisenbarth, H. A. Erlich, and M. Rewers Timing of Initial Cereal Exposure in Infancy and Risk of Islet Autoimmunity JAMA, October 1, 2003; 290(13): 1713 - 1720. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Krischer, D. D. Cuthbertson, L. Yu, T. Orban, N. Maclaren, R. Jackson, W. E. Winter, D. A. Schatz, J. P. Palmer, and G. S. Eisenbarth Screening Strategies for the Identification of Multiple Antibody-Positive Relatives of Individuals with Type 1 Diabetes J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 103 - 108. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. V. Tarbell, M. Lee, E. Ranheim, C. C. Chao, M. Sanna, S.-K. Kim, P. Dickie, L. Teyton, M. Davis, and H. McDevitt CD4+ T Cells from Glutamic Acid Decarboxylase (GAD)65-specific T Cell Receptor Transgenic Mice Are Not Diabetogenic and Can Delay Diabetes Transfer J. Exp. Med., August 19, 2002; 196(4): 481 - 492. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. LaGasse, M. S. Brantley, N. J. Leech, R. E. Rowe, S. Monks, J. P. Palmer, G. T. Nepom, D. K. McCulloch, and W. A. Hagopian Successful Prospective Prediction of Type 1 Diabetes in Schoolchildren Through Multiple Defined Autoantibodies: An 8-year follow-up of the Washington State Diabetes Prediction Study Diabetes Care, March 1, 2002; 25(3): 505 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yu, D. D. Cuthbertson, N. Maclaren, R. Jackson, J. P. Palmer, T. Orban, G. S. Eisenbarth, and J. P. Krischer Expression of GAD65 and Islet Cell Antibody (ICA512) Autoantibodies Among Cytoplasmic ICA+ Relatives Is Associated With Eligibility for the Diabetes Prevention Trial-Type 1 Diabetes, August 1, 2001; 50(8): 1735 - 1740. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Berghs, F. Ferracci, E. Maksimova, S. Gleason, N. Leszczynski, M. Butler, P. De Camilli, and M. Solimena Autoimmunity to beta IV spectrin in paraneoplastic lower motor neuron syndrome PNAS, June 5, 2001; 98(12): 6945 - 6950. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Brooks-Worrell, V. H. Gersuk, C. Greenbaum, and J. P. Palmer Intermolecular Antigen Spreading Occurs During the Preclinical Period of Human Type 1 Diabetes J. Immunol., April 15, 2001; 166(8): 5265 - 5270. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Greenbaum, D. Cuthbertson, and J. P. Krischer Type 1 Diabetes Manifested Solely by 2-h Oral Glucose Tolerance Test Criteria Diabetes, February 1, 2001; 50(2): 470 - 476. [Abstract] [Full Text] |
||||
![]() |
C. J. Greenbaum, D. A. Schatz, D. Cuthbertson, A. Zeidler, G. S. Eisenbarth, and J. P. Krischer Islet Cell Antibody-Positive Relatives with Human Leukocyte Antigen DQA10102, DQB10602: Identification by the Diabetes Prevention Trial-Type 1 J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1255 - 1260. [Abstract] [Full Text] |
||||
![]() |
R. H. Slover and G. S. Eisenbarth Prevention of Type I Diabetes and Recurrent {beta}-Cell Destruction of Transplanted Islets Endocr. Rev., April 1, 1997; 18(2): 241 - 258. [Abstract] [Full Text] |
||||
![]() |
L. Yu, D. T. Robles, N. Abiru, P. Kaur, M. Rewers, K. Kelemen, and G. S. Eisenbarth Early expression of antiinsulin autoantibodies of humans and the NOD mouse: Evidence for early determination of subsequent diabetes PNAS, February 15, 2000; 97(4): 1701 - 1706. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |